110 related articles for article (PubMed ID: 19724878)
1. Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects.
Zong J; Peng Q; Wang Q; Zhang T; Fan D; Xu X
Oncol Rep; 2009 Oct; 22(4):953-61. PubMed ID: 19724878
[TBL] [Abstract][Full Text] [Related]
2. HSP70 and modified HPV 16 E7 fusion gene without the addition of a signal peptide gene sequence as a candidate therapeutic tumor vaccine.
Zong J; Wang C; Wang Q; Peng Q; Xu Y; Xie X; Xu X
Oncol Rep; 2013 Dec; 30(6):3020-6. PubMed ID: 24065282
[TBL] [Abstract][Full Text] [Related]
3. Human hsp70 and HPV16 oE7 fusion protein vaccine induces an effective antitumor efficacy.
Zong J; Wang C; Liu B; Liu M; Cao Y; Sun X; Yao Y; Sun G
Oncol Rep; 2013 Jul; 30(1):407-12. PubMed ID: 23660931
[TBL] [Abstract][Full Text] [Related]
4. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.
Liu DW; Tsao YP; Kung JT; Ding YA; Sytwu HK; Xiao X; Chen SL
J Virol; 2000 Mar; 74(6):2888-94. PubMed ID: 10684306
[TBL] [Abstract][Full Text] [Related]
6. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
7. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
Li H; Ou X; Xiong J
Gynecol Oncol; 2007 Mar; 104(3):564-71. PubMed ID: 17081598
[TBL] [Abstract][Full Text] [Related]
8. Immunological responses and anti-tumor effects of HPV16/18 L1-L2-E7 multiepitope fusion construct along with curcumin and nanocurcumin in C57BL/6 mouse model.
Kayyal M; Bolhassani A; Noormohammadi Z; Sadeghizadeh M
Life Sci; 2021 Nov; 285():119945. PubMed ID: 34516991
[TBL] [Abstract][Full Text] [Related]
9. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH
Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679
[TBL] [Abstract][Full Text] [Related]
10. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.
Chu NR; Wu HB; Wu T; Boux LJ; Siegel MI; Mizzen LA
Clin Exp Immunol; 2000 Aug; 121(2):216-25. PubMed ID: 10931134
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.
Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Rice CM; Ling M; Wu TC
J Immunol; 2001 May; 166(10):6218-26. PubMed ID: 11342644
[TBL] [Abstract][Full Text] [Related]
13. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
Wang QY; Xu YF; Fan DS; Peng QL; Zhang T; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
Hsu KF; Hung CF; Cheng WF; He L; Slater LA; Ling M; Wu TC
Gene Ther; 2001 Mar; 8(5):376-83. PubMed ID: 11313814
[TBL] [Abstract][Full Text] [Related]
15. A Genetically Modified attenuated
Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
Chen CH; Wang TL; Hung CF; Yang Y; Young RA; Pardoll DM; Wu TC
Cancer Res; 2000 Feb; 60(4):1035-42. PubMed ID: 10706121
[TBL] [Abstract][Full Text] [Related]
17. Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles.
Lin CT; Hung CF; Juang J; He L; Lin KY; Kim TW; Wu TC
Mol Ther; 2003 Oct; 8(4):559-66. PubMed ID: 14529828
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
Hung CF; Hsu KF; Cheng WF; Chai CY; He L; Ling M; Wu TC
Cancer Res; 2001 Feb; 61(3):1080-8. PubMed ID: 11221836
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model.
Qian X; Lu Y; Liu Q; Chen K; Zhao Q; Song J
Immunol Lett; 2006 Feb; 102(2):191-201. PubMed ID: 16242781
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.
Trimble C; Lin CT; Hung CF; Pai S; Juang J; He L; Gillison M; Pardoll D; Wu L; Wu TC
Vaccine; 2003 Sep; 21(25-26):4036-42. PubMed ID: 12922140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]